Teva Announces Conference Call for Second Quarter Financial Results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) recently shared its plans to provide insights into its financial results for the second quarter of 2025. The report will be released on July 30, 2025, at 7:00 a.m. ET, followed by a live conference call scheduled for 8:00 a.m. ET on the same day.
How to Participate in the Conference Call
If you're interested in joining the call, Teva encourages early registration. By registering in advance, participants can obtain a local or toll-free phone number along with a personal PIN, ensuring a smooth connection on the day of the event. Recently, technology has made it easier for investors and stakeholders to engage in these discussions, allowing everyone to stay informed.
Webcast Access and Replay
Teva's conference call will also be available via a live webcast, providing an excellent opportunity for those unable to join by phone. After the call, a replay of the webcast will be accessible on Teva's website within 24 hours, giving stakeholders flexibility in accessing the information shared.
About Teva: A Global Health Leader
Teva Pharmaceutical Industries has established itself as a significant player in the biopharmaceutical sector. For over 120 years, Teva has committed itself to improving health globally. As an integral part of delivering effective healthcare solutions, the company's diverse range of products includes both generics and innovator medicines. Today, Teva operates in 57 markets with a strong workforce of around 37,000 employees dedicated to advancing healthcare.
Innovative Approaches
Teva is focused on the future of medicine, utilizing its global network to innovate and produce new therapies that align with the evolving needs of patients. Their dedication to patient-centered solutions drives their research and development strategies.
Commitment to Community Health
By championing generics alongside innovative therapies, Teva addresses diverse patient requirements. Their ongoing efforts emphasize the importance of accessible, reliable medications, showcasing a passion for community health and wellbeing.
Contact Information for Media and Investors
Teva also maintains clear channels for communication both for media inquiries and investor relations. For media-related queries, interested parties can reach out via email. Similarly, investors looking for more information regarding the company’s financial performance or ongoing strategies can contact investor relations.
Media Contact
For media inquiries, please contact: TevaCommunicationsNorthAmerica@tevapharm.com.
Investor Relations
For investor-related questions, reach out to: TevaIR@Tevapharm.com.
Frequently Asked Questions
1. What is the date for the upcoming financial call?
The financial call is scheduled for July 30, 2025, at 8:00 a.m. ET.
2. How can I listen to the conference call?
Participants can register in advance for a phone line or listen to the live webcast available on Teva's website.
3. What information will be shared during the conference call?
Teva will discuss their financial results for the second quarter of 2025 and highlight key operational strategies.
4. Is there a way to access a replay of the conference call?
Yes, a replay of the webcast will be available on Teva's website within 24 hours after the call concludes.
5. Where can I find more information about Teva?
More information about Teva and its initiatives can be found at www.tevapharm.com.
